Skip to main content
. 2020 Nov 25;11:577971. doi: 10.3389/fneur.2020.577971

Figure 1.

Figure 1

Myeloid-derived suppressor cells (MDSCs) were measured in stroke patients in comparison to healthy controls. Monocytic MDSCs (Mo-MDSC; CD11b+/CD14+/HLA-DRdim/−) (A); granulocytic or polymorphonuclear MDSCs (PMN-MDSCs; CD11b+/CD15+/CD14) (B); and early MDSCs (e-MDSCs; Lin/HLA-DR/CD33+/CD11b+) (C) were measured in 27 stroke patients (black dots) in comparison to 16 healthy age-matched controls (white dots) on days 1, 3, and 5 after stroke. Cells were stained extracellularly and analyzed by flow cytometry (LSR II, BD). Median and interquartile range are provided. ***p < 0.001.